These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9727881)

  • 21. Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.
    Yao L; Mizushige K; Noma T; Murakami K; Ohmori K; Matsuo H
    Heart; 2000 Aug; 84(2):209. PubMed ID: 10908265
    [No Abstract]   [Full Text] [Related]  

  • 22. A treatment for Mr WP: thiazolidinediones after troglitazone.
    Montague CT
    Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
    [No Abstract]   [Full Text] [Related]  

  • 23. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
    Teter ML
    Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
    [No Abstract]   [Full Text] [Related]  

  • 24. The glitazones: proceed with caution.
    Krische D
    West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of troglitazone in treating the insulin resistance syndrome.
    Granberry MC; Schneider EF; Fonseca VA
    Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus.
    Minamikawa J; Yamauchi M; Inoue D; Koshiyama H
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1041-2. PubMed ID: 9506772
    [No Abstract]   [Full Text] [Related]  

  • 27. Troglitazone: monotherapy indication.
    Lisi DM
    Arch Intern Med; 1998 Feb; 158(4):412. PubMed ID: 9487241
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
    Ohmura E; Hosaka D; Imai Y; Kawazu S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
    [No Abstract]   [Full Text] [Related]  

  • 29. New drugs for diabetes.
    Tack CJ; Smits P
    Neth J Med; 1999 Nov; 55(5):209-11. PubMed ID: 10593129
    [No Abstract]   [Full Text] [Related]  

  • 30. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 1999 Sep; 22(9):1568-77. PubMed ID: 10480527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic injury due to troglitazone.
    Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
    Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
    [No Abstract]   [Full Text] [Related]  

  • 32. Troglitazone's effect on lipoprotein(a) levels.
    Ovalle F; Bell DS
    Diabetes Care; 1999 May; 22(5):859-60. PubMed ID: 10332700
    [No Abstract]   [Full Text] [Related]  

  • 33. Increase of lipoprotein (a) with troglitazone.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Tominaga Y
    Lancet; 1997 Dec; 350(9093):1748-9. PubMed ID: 9413470
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
    Samraj GP; Kuritzky L; Quillen DM
    Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA reviews troglitazone.
    Donnelly R
    Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary edema associated with troglitazone therapy.
    Hirsch IB; Kelly J; Cooper S
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
    [No Abstract]   [Full Text] [Related]  

  • 38. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
    Murase Y; Wakasugi T; Yagi K; Mabuchi H
    Diabetes Care; 2000 Jan; 23(1):131-2. PubMed ID: 10857989
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipoatrophy, lipodystrophy, and insulin resistance.
    Ganda OP
    Ann Intern Med; 2000 Aug; 133(4):304-6. PubMed ID: 10929174
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of troglitazone.
    Umland EM; Romanelli AM
    Ann Pharmacother; 1999 Feb; 33(2):229-32. PubMed ID: 10084419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.